Hospital News and Research

RSS

Study: LABA can be effective step-up treatment for children whose asthma is not well controlled

For children whose asthma is not well controlled and on low doses of inhaled corticosteroids, a long-acting beta-agonist (LABA) may be the most effective of three possible step-up treatments. National Jewish clinician-scientists Stanley Szefler, Joseph Spahn, Ronina Covar Gary Larsen and Lynn Taussig, and colleagues in the NIH-funded Childhood Asthma Research and Education Network published their findings March 2, 2010, online in the New England Journal of Medicine.

3 Mar 2010

Total economic impact of foodborne illness across the nation to be a combined $152 billion annually

A new study by a former U.S. Food and Drug Administration (FDA) economist estimates the total economic impact of foodborne illness across the nation to be a combined $152 billion annually.

3 Mar 2010

Stanford University Medical Center buys ASTI's Ecotones Duet Adaptive Sleep Sound Machines

Adaptive Sound Technologies, Inc. (ASTI) announced today that the Stanford University Medical Center has purchased Ecotones Duet Adaptive Sleep Sound Machines. "It is well known that noise in hospitals affects patient comfort and recovery, as well as staff performance. ASTI's adaptive technology can help with these problems," stated Sam Nicolino, President and CEO of ASTI.

3 Mar 2010

Royal Philips Electronics, Microsoft collaborate to improve Philips Healthcare's efficiency and productivity

Royal Philips Electronics today announced collaboration with Microsoft Corp. to build on Philips Healthcare's foundation of healthcare informatics and advanced clinical decision support offerings that drive efficiency and effectiveness at the point of care.

From Philips Healthcare 3 Mar 2010

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

UHSM uses Aruba Networks’ VBN solution to increase quality of antenatal services

Aruba Networks, Inc., a global leader in 802.11n wireless LANs and secure mobility solutions, today announced that the University Hospital of South Manchester NHS Foundation Trust in the United Kingdom is using Aruba’s Virtual Branch Networking (VBN) solution to increase the quality of antenatal services delivered to the local community.

3 Mar 2010

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Robotic surgical technology with its three-dimensional, high-definition view gives surgeons the sensation of touch, even as they operate from a remote console. A new study describes the phenomenon, called intersensory integration, and reports that surgical outcomes for prostate cancer surgery using minimally invasive robotic technology compare favorably with traditional invasive surgery.

3 Mar 2010

Warren Buffet supports Senate bill, Franken and Ryan pushing their health reform ideas

CNBC interviewed billionaire investor Warren Buffett, who "called the nation's health care spending 'untenable,' comparing 'out of control' costs to a 'tapeworm eating at our economic body.' While he would support the current Senate health care reform bill if pressed, Buffett says he would prefer a 'Plan C' that would control costs by changing the financial incentives of the system" (Crippen, 3/1).

3 Mar 2010

Patient Safety Authority highlights analysis of data related to insulin medication errors

Pennsylvania healthcare facilities submitted over 2,600 event reports that involved the use of insulin products to the Patient Safety Authority where more than 52 percent led to situations in which a patient may have or actually received the wrong dose or no dose of insulin. The data raises awareness of a broader issue that is highlighted in the 2010 March Pennsylvania Patient Safety Advisory.

3 Mar 2010

Common diabetes therapies may increase cancer risk, but more research needed

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

3 Mar 2010

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall.

From Baxter International Inc. 3 Mar 2010

Sec. of State Clinton arrives in Chile 'to offer support' as country deals with earthquake

During a scheduled trip to Latin America, Secretary of State Hillary Rodham Clinton arrived in Chile Tuesday "to offer support" after a major earthquake struck over the weekend, Bloomberg/BusinessWeek reports (Boyd/Smith, 3/2).

3 Mar 2010

Miami-based company introduces ER Texting services for national hospital chain

ER Texting, Inc., a Miami-based healthcare technology company today announced the launch of its ER Texting services for hospitals nationwide.

3 Mar 2010

GHX unveils Procurement Suite spend management solution for healthcare providers

GHX today unveiled its Procurement Suite spend management solution for healthcare providers, designed to enable more strategic and cost-effective purchasing decisions. With Procurement Suite, hospitals can gain better control over non-file, off-contract spending. The new suite of products represents the first step to managing physician-preference items.

3 Mar 2010

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

Data demonstrating the effectiveness of KALBITOR (ecallantide) to treat hereditary angioedema (HAE) acute attacks by primary attack location were provided in an oral presentation yesterday at the American Academy of Allergy, Asthma and Immunology 2010 Annual Meeting in New Orleans.

3 Mar 2010

Benefits of aspirin therapy for patients with peripheral artery disease remain unproven

Individuals who were identified as being at increased risk of cardiovascular or cerebrovascular events based on screening for low ankle brachial index, a type of pressure measurement used in the diagnosis of peripheral artery disease, did not significantly reduce their risk of these events with the use of aspirin, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Pioneering stem cell research could revolutionize treatments for diabetes and Alzheimer's disease

A heart patient's own skin cells soon could be used to repair damaged cardiac tissue thanks to pioneering stem cell research of the University of Houston's newest biomedical scientist, Robert Schwartz.

3 Mar 2010

Findings could lead to new cancer-fighting drugs

A new study is providing insight into how estrogen fuels many breast cancers, and researchers say the findings could lead to new cancer-fighting drugs.

3 Mar 2010

ICU survivors face high risk of death in following years, says study

An analysis of Medicare data indicates that elderly patients who are hospitalized in an intensive care unit (ICU) and survive to be discharged from the hospital have a high rate of death in the following three years, and that, in particular, patients who receive mechanical ventilation have a substantially increased rate of death compared with both hospital and general population controls in the first several months after hospital discharge, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Hospital News and Research

Study: LABA can be effective step-up treatment for children whose asthma is not well controlled

Total economic impact of foodborne illness across the nation to be a combined $152 billion annually

Stanford University Medical Center buys ASTI's Ecotones Duet Adaptive Sleep Sound Machines

Royal Philips Electronics, Microsoft collaborate to improve Philips Healthcare's efficiency and productivity

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

UHSM uses Aruba Networks’ VBN solution to increase quality of antenatal services

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Warren Buffet supports Senate bill, Franken and Ryan pushing their health reform ideas

Patient Safety Authority highlights analysis of data related to insulin medication errors

Common diabetes therapies may increase cancer risk, but more research needed

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Sec. of State Clinton arrives in Chile 'to offer support' as country deals with earthquake

Miami-based company introduces ER Texting services for national hospital chain

GHX unveils Procurement Suite spend management solution for healthcare providers

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

Benefits of aspirin therapy for patients with peripheral artery disease remain unproven

Pioneering stem cell research could revolutionize treatments for diabetes and Alzheimer's disease

Findings could lead to new cancer-fighting drugs

ICU survivors face high risk of death in following years, says study

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News